Core Viewpoint - The investment by Wens Foodstuff Group in Qingdao Shuang'an Bio-Tech Co., Ltd. aims to strengthen its core business while exploring strategic opportunities in the pet food sector, enhancing sustainable development and risk resilience [1][3]. Investment Details - Wens Investment plans to invest no more than 147 million yuan in Qingdao Shuang'an, acquiring approximately 22.19% of its equity and subscribing to an additional capital increase of 103 million yuan [4]. - After the transaction, Wens Investment will hold 48.18% of Qingdao Shuang'an's equity, making it the largest shareholder [4][5]. Company Background - Qingdao Shuang'an, established in 2010, operates in the pet food industry, including the development and production of pet food and health products, with brands like Black Nose and Cat Doctor [5]. - The company is projected to achieve revenues of 407 million yuan and a net profit of 12.16 million yuan by 2025, with total assets of 506 million yuan and net assets of 144 million yuan [6]. Market Context - The pet consumption market in China is expected to grow significantly, reaching 405 billion yuan by 2028, with pet food accounting for 53.7% of the market share [7]. - The competitive landscape includes major players like Guai Bao Pet and Zhong Chong Co., with significant revenue figures, highlighting the challenges faced by Qingdao Shuang'an [9]. Strategic Implications - The investment is seen as a strategic move for Wens Foodstuff Group to diversify and stabilize its business amid declining profits, with a projected net profit drop of 40.73%-46.12% in 2025 [9][10]. - By acquiring Qingdao Shuang'an, Wens aims to leverage synergies in cost reduction, product upgrades, and channel sharing, potentially enhancing future profit growth [10].
农牧巨头切入宠物赛道!温氏拟1.47亿元收购青岛双安股权